CMS-D008

CMS-D008 · Shenzhen Kangzhe Biotechnology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMS-D008, covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of Ascending Doses of CMS-D008 in Healthy and Overweight/Obese Adults [Phase 1]